List of 5α-reductase inhibitors
This is a list of 5α-reductase inhibitors (5α-RIs), drugs which inhibit one or more isoforms of the enzyme 5α-reductase. This enzyme is responsible for the conversion of the androgen hormone testosterone into the more potent dihydrotestosterone (DHT) and is essential for the production of neurosteroids like allopregnanolone, tetrahydrodeoxycorticosterone (THDOC), and 3α-androstanediol from progesterone, deoxycorticosterone, and DHT, respectively. 5α-Reductase inhibitors have medical applications in the treatment of benign prostatic hyperplasia, androgenic alopecia (pattern hair loss), and hirsutism (excessive hair growth).
Pharmaceutical drugs
5α-RIs that are used in medicine include the following:
- Alfatradiol (Ell-Cranell Alpha, Pantostin)
- Dutasteride (Avodart) – inhibits types 1, 2, and 3
- Epristeride (Aipuliete, Chuanliu) – inhibits type 2
- Finasteride (Proscar, Propecia) – inhibits types 2 and 3
- Saw palmetto extract (Permixon) – inhibits types 1 and 2
Experimental drugs
5α-RIs that were under development for potential clinical use but were never marketed or are used in research include the following:
- 4-MA – inhibits types 1 and 2 (IC50 = 8.5 nM), but also 3β-HSD inhibitor, investigated extensively but found to be hepatotoxic[1]
- 17β-Carboxy-4-androsten-3-one[2][3]
- AS-97004
- Azelaic Acid[4]
- Bexlosteride (LY-300502) – inhibits type 1
- CGP-53153
- Efomycin G (SNA 4606-2)
- EM-402
- FCE-28260 – inhibits types 1 and 2
- FK-143
- FR-146687
- G-20000
- Izonsteride (LY-320236) – inhibits types 1 and 2
- L-10
- L-39
- L-697818
- L-751788 (16-((4-chlorophenyl)oxy)-4,7-dimethyl-4-azaandronstan-3-one)
- Lapisteride (CS-891) – inhibits types 1 and 2
- LY-191704
- LY-266111
- MK-386 (L-733692) – inhibits type 1
- MK-434 – inhibits type 2[5]
- MK-963 (L-654066) – inhibits type 2
- ONO-3805 (ONO-RI-3805)
- PHL-00801 (Prostatonin; PY 102/UR 102; Pygeum africanum/Urtica dioica extract)
- PNU-157706 – inhibits types 1 and 2[6]
- Steroidal oximes[7][8]
- Turosteride (FCE-26073) – inhibits type 2 and to a 15-fold lesser extent type 1
- Z-350 – also an α1-adrenergic receptor antagonist[9]
Herbs and other inhibitors
Many plants, as well as their associated phytochemical constituents, have inhibitory effects on 5α-reductase.[10] In addition, many of these compounds are also phytoestrogens.[11] Examples include the following:
- Zinc.[12]
- Riboflavin (vitamin B2).[13]
- Azelaic acid,[12] (sometimes combined with minoxidil hair solution).
- β-Sitosterol,[14] is just one of the many phytosterols.
- Polyphenols[15]
- Alizarin,
- Curcumin, the principal curcuminoid of turmeric.
- Green tea catechins, including (-)-epicatechin-3-gallate, and (-)-epigallo-catechin-3-gallate (EGCG).[16]
- Valoneic acid dilactone and gallagyldilactone are two hydrolysable tannin polyphenols isolated from the heartwood of Shorea laeviforia[17] and oaks species such as the North American white oak (Quercus alba) and European red oak (Quercus robur) are inhibitory.[18]
- Angelica koreana [19][20]
- Garden Balsam or Rose Balsam (Impatiens balsamina)[21]
- Pollen of Turnip, turnip rape, fast plants, field mustard, or turnip mustard (Brassica rapa)[22]
- Dodder (Cuscuta reflexa)[23]
- Euphorbia jolkinii[24][25]
- Lingzhi mushroom or Reishi mushroom (Ganoderma lucidum)[26][27][28][29]
- Ganoderic acid,[30] or Ganoderol B are thought to be the compounds in the mushroom that are specifically active.[31]
- Chinese Knotweed (Polygonum multiflorum),[32] contains resveratrol-like Stilbenoids.
- Black Pepper leaf extract (Piper nigrum) [33]
- Red Stinkwood (Pygeum africanum)[34]
- Saw Palmetto (Serenoa repens, active substance possibly lauric acid[35])[36][37]
- The berries of saw palmetto (Serenoa repens), a small palm native to the south east United States, possess a dual 5a-reductase inhibition activity, due to their high content of phytosterols: β-sitosterol, stigmasterol, lupeol, lupenone, and cycloartenol. Permixon® was launched in Europe in 1984 but has no FDA approval. The lipido-sterol extract markedly inhibits both the human isoenzymes. Type 1 isoenzyme is noncompetitively (Ki = 7.2 μg/mL) and type 2 isoenzyme uncompetitively (Ki = 4.9 μg/mL) inhibited[38]
- Pine (Pinus sp. resin, active substance abietic acid)[39]
- Ku Shen or Bitter root (Sophora flavescens)[40]
- Japanese hedge parsley (Torilis japonica)[41]
- Eastern Arborvitae, Northern Whitecedar (Thuja occidentalis)[42]
- Spore of Japanese climbing fern (Lygodium japonicum)[43]
- The relative inhibitory potencies of unsaturated fatty acids are, in decreasing order: Gamma-Linolenic acid, alpha-linolenic acid, linoleic acid, palmitoleic acid, oleic acid, and myristoleic acid.[44]
- Medium chain fatty acids such as those found in coconut and the kernel of many palm fruits have also been found to inhibit 5α-reductase.[45]
- Certain pesticides are able to disturb the sex steroid hormone system and to act as antiandrogens.[46]
- Amla(Phyllanthus emblica)[47]
Herbs like Pyllanthus Emblica[47] possess 5 alpha reductase inhibition properties and may decrease scalp dht when used topically, thereby facilitating new hair growth. Hence, extract of these herbs may be beneficial for Androgenic alopecia.
These supplements have limited testing in human clinical trials, and their potential for the treatment of BPH, androgenic alopecia, and related conditions is unknown.
References
- ↑ Guarna A, Occhiato EG, Danza G, Conti A, Serio M (1998). "5 alpha-reductase inhibitors, chemical and clinical models". Steroids. 63 (5–6): 355–61. doi:10.1016/S0039-128X(98)00020-8. PMID 9618802.
- ↑ Hsia SL, Voigt W (March 1974). "Inhibition of dihydrotestosterone formation: an effective means of blocking androgen action in hamster sebaceous gland". The Journal of Investigative Dermatology. 62 (3): 224–7. doi:10.1111/1523-1747.ep12676791. PMID 4361987.
- ↑ "Steroid 5α α α α-Reductase Inhibitors". ResearchGate. 2014-05-21. Retrieved 2014-06-08.
- ↑ https://www.researchgate.net/publication/227798711_Inhibition_of_5_-reductase_activity_in_human_skin_by_zinc_and_azelaic_acid
- ↑ Cohen SM, Werrmann JG, Rasmusson GH, Tanaka WK, Malatesta PF, Prahalada S, Jacobs JG, Harris G, Nett TM (February 1995). "Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression". The Prostate. 26 (2): 55–71. doi:10.1002/pros.2990260202. PMID 7531846.
- ↑ di Salle E, Giudici D, Radice A, Zaccheo T, Ornati G, Nesi M, Panzeri A, Délos S, Martin PM (February 1998). "PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor". The Journal of Steroid Biochemistry and Molecular Biology. 64 (3–4): 179–86. doi:10.1016/S0960-0760(97)00158-1. PMID 9605412.
- ↑ Hartmann RW, Hector M, Haidar S, Ehmer PB, Reichert W, Jose J (November 2000). "Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17 alpha-hydroxylase/C17-20-lyase) and 5 alpha-reductase types 1 and 2". Journal of Medicinal Chemistry. 43 (22): 4266–77. doi:10.1021/jm001008m. PMID 11063622.
- ↑ Flores E, Bratoeff E, Cabeza M, Ramirez E, Quiroz A, Heuze I (May 2003). "Steroid 5alpha-reductase inhibitors". Mini Reviews in Medicinal Chemistry. 3 (3): 225–37. doi:10.2174/1389557033488196. PMID 12570838.
- ↑ Fukuta Y, Fukuda Y, Higashino R, Yoshida K, Ogishima M, Tamaki H, Takei M (September 1999). "Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo". The Journal of Pharmacology and Experimental Therapeutics. 290 (3): 1013–8. PMID 10454472.
- ↑ Nahata A, Dixit VK (August 2014). "Evaluation of 5α-reductase inhibitory activity of certain herbs useful as antiandrogens". Andrologia. 46 (6): 592–601. doi:10.1111/and.12115. PMID 23710567.
- ↑ Stansbury, Jillian E. "Phytoestrogen review" (PDF).
- 1 2 Stamatiadis D, Bulteau-Portois MC, Mowszowicz I (November 1988). "Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid". The British Journal of Dermatology. 119 (5): 627–32. doi:10.1111/j.1365-2133.1988.tb03474.x. PMID 3207614.
- ↑ Nakayama O, Yagi M, Kiyoto S, Okuhara M, Kohsaka M (December 1990). "Riboflavin, a testosterone 5 alpha-reductase inhibitor". The Journal of Antibiotics. 43 (12): 1615–6. doi:10.7164/antibiotics.43.1615. PMID 2276981.
- ↑ Cabeza M, Bratoeff E, Heuze I, Ramírez E, Sánchez M, Flores E (2003). "Effect of beta-sitosterol as inhibitor of 5 alpha-reductase in hamster prostate". Proceedings of the Western Pharmacology Society. 46: 153–5. PMID 14699915.
- ↑ Hiipakka RA, Zhang HZ, Dai W, Dai Q, Liao S (March 2002). "Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols". Biochemical Pharmacology. 63 (6): 1165–76. doi:10.1016/s0006-2952(02)00848-1. PMID 11931850.
- ↑ Liao S, Lin J, Dang MT, Zhang H, Kao YH, Fukuchi J, Hiipakka RA (April 2001). "Growth suppression of hamster flank organs by topical application of catechins, alizarin, curcumin, and myristoleic acid". Archives of Dermatological Research. 293 (4): 200–5. doi:10.1007/s004030000203. PMID 11380153.
- ↑ Yoshio H, Ryuichiro K, Kokki S (2003). "5A-Reductase inhibitory tannin-related compounds isolated from Shorea laeviforia". Journal of Wood Science. 49 (4): 339–343. doi:10.1007/s10086-002-0481-y.
- ↑ Mämmelä P, Savolainen H, Lindroos L, Kangas J, Vartiainen T (September 2000). "Analysis of oak tannins by liquid chromatography-electrospray ionisation mass spectrometry". Journal of Chromatography A. 891 (1): 75–83. doi:10.1016/S0021-9673(00)00624-5. PMID 10999626.
- ↑ Plants for a Future: Angelica koreana
- ↑ Seo EK, Kim KH, Kim MK, Cho MH, Choi E, Kim K, Mar W (February 2002). "Inhibitors of 5alpha -reductase type I in LNCaP cells from the roots of Angelica koreana". Planta Medica. 68 (2): 162–3. doi:10.1055/s-2002-20258. PMID 11859469.
- ↑ Oku H, Ishiguro K (2002). "Cyclooxygenase-2 inhibitory 1,4-naphthoquinones from Impatiens balsamina L.". Biological & Pharmaceutical Bulletin. 25 (5): 658–60. doi:10.1248/bpb.25.658.
- ↑ Li YH, Yang YF, Li K, Jin LL, Yang NY, Kong DY (April 2009). "5 alpha-reductase and aromatase inhibitory constituents from Brassica rapa L. pollen". Chemical & Pharmaceutical Bulletin. 57 (4): 401–4. doi:10.1248/cpb.57.401. PMID 19336936.
- ↑ Pandit S, Chauhan NS, Dixit VK (September 2008). "Effect of Cuscuta reflexa Roxb on androgen-induced alopecia". Journal of Cosmetic Dermatology. 7 (3): 199–204. doi:10.1111/j.1473-2165.2008.00389.x. PMID 18789055.
- ↑ Flora of China: Euphorbia jolkinii
- ↑ Park SH, Kim JA, Hua XG (2005). "Isolation of 5α-reductase inhibitors from Euphorbia jolkinii". Korean Journal of Pharmacognosy. 36 (1): 9–16.
- ↑ Fujita R, Liu J, Shimizu K, Konishi F, Noda K, Kumamoto S, Ueda C, Tajiri H, Kaneko S, Suimi Y, Kondo R (October 2005). "Anti-androgenic activities of Ganoderma lucidum". Journal of Ethnopharmacology. 102 (1): 107–12. doi:10.1016/j.jep.2005.05.041. PMID 16029938.
- ↑ Liu J, Kurashiki K, Shimizu K, Kondo R (February 2006). "5alpha-reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum". Biological & Pharmaceutical Bulletin. 29 (2): 392–5. doi:10.1248/bpb.29.392. PMID 16462054.
- ↑ Liu J, Tamura S, Kurashiki K, Shimizu K, Noda K, Konishi F, Kumamoto S, Kondo R (February 2009). "Anti-androgen effects of extracts and compounds from Ganoderma lucidum". Chemistry & Biodiversity. 6 (2): 231–43. doi:10.1002/cbdv.200800019. PMID 19235153.
- ↑ Noguchi M, Kakuma T, Tomiyasu K, Yamada A, Itoh K, Konishi F, Kumamoto S, Shimizu K, Kondo R, Matsuoka K (September 2008). "Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms". Asian Journal of Andrology. 10 (5): 777–85. doi:10.1111/j.1745-7262.2008.00361.x. PMID 18097505.
- ↑ Liu J, Shiono J, Shimizu K, Kukita A, Kukita T, Kondo R (April 2009). "Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor". Bioorganic & Medicinal Chemistry Letters. 19 (8): 2154–7. doi:10.1016/j.bmcl.2009.02.119. PMID 19289282.
- ↑ Liu J, Shimizu K, Konishi F, Kumamoto S, Kondo R (July 2007). "The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum". Bioorganic & Medicinal Chemistry. 15 (14): 4966–72. doi:10.1016/j.bmc.2007.04.036. PMID 17499997.
- ↑ Cho CH, Bae JS, Kim YU (June 2010). "5alpha-reductase inhibitory components as antiandrogens from herbal medicine". Journal of Acupuncture and Meridian Studies. 3 (2): 116–8. doi:10.1016/S2005-2901(10)60021-0. PMID 20633525.
- ↑ Hirata N, Tokunaga M, Naruto S, Iinuma M, Matsuda H (December 2007). "Testosterone 5alpha-reductase inhibitory active constituents of Piper nigrum leaf". Biological & Pharmaceutical Bulletin. 30 (12): 2402–5. doi:10.1248/bpb.30.2402. PMID 18057734.
- ↑ Edgar AD, Levin R, Constantinou CE, Denis L (2007). "A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS". Neurourology and Urodynamics. 26 (4): 458–463. doi:10.1002/nau.20136. PMID 17397059.
- ↑ Raynaud JP, Cousse H, Martin PM (October 2002). "Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon". The Journal of Steroid Biochemistry and Molecular Biology. 82 (2–3): 233–9. doi:10.1016/S0960-0760(02)00187-5. PMID 12477490.
- ↑ Pais P (August 2010). "Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5alpha-reductase II". Advances in Therapy. 27 (8): 555–63. doi:10.1007/s12325-010-0041-6. PMID 20623347.
- ↑ Abe M, Ito Y, Oyunzul L, Oki-Fujino T, Yamada S (April 2009). "Pharmacologically relevant receptor binding characteristics and 5alpha-reductase inhibitory activity of free Fatty acids contained in saw palmetto extract". Biological & Pharmaceutical Bulletin. 32 (4): 646–50. doi:10.1248/bpb.32.646. PMID 19336899.
- ↑ Iehlé C, Délos S, Guirou O, Tate R, Raynaud JP, Martin PM (September 1995). "Human prostatic steroid 5 alpha-reductase isoforms--a comparative study of selective inhibitors". The Journal of Steroid Biochemistry and Molecular Biology. 54 (5–6): 273–9. doi:10.1016/0960-0760(95)00134-L. PMID 7577710.
- ↑ Roh SS, Park MK, Kim YU (2010). "Abietic acid from Resina Pini of Pinus species as a testosterone 5α-reductase inhibitor". Journal of Health Science. 56 (4): 451–455. doi:10.1248/jhs.56.451.
- ↑ Roh SS, Kim CD, Lee MH, Hwang SL, Rang MJ, Yoon YK (October 2002). "The hair growth promoting effect of Sophora flavescens extract and its molecular regulation". Journal of Dermatological Science. 30 (1): 43–9. doi:10.1016/s0923-1811(02)00060-9. PMID 12354419.
- ↑ Park WS, Son ED, Nam GW, Kim SH, Noh MS, Lee BG, Jang IS, Kim SE, Lee JJ, Lee CH (May 2003). "Torilin from Torilis japonica, as a new inhibitor of testosterone 5 alpha-reductase". Planta Medica. 69 (5): 459–61. doi:10.1055/s-2003-39717. PMID 12802730.
- ↑ Park WS, Lee CH, Lee BG, Chang IS (April 2003). "The extract of Thujae occidentalis semen inhibited 5alpha-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse". Journal of Dermatological Science. 31 (2): 91–8. doi:10.1016/s0923-1811(02)00146-9. PMID 12670719.
- ↑ Matsuda H, Yamazaki M, Naruo S, Asanuma Y, Kubo M (May 2002). "Anti-androgenic and hair growth promoting activities of Lygodii spora (spore of Lygodium japonicum) I. Active constituents inhibiting testosterone 5alpha-reductase". Biological & Pharmaceutical Bulletin. 25 (5): 622–6. doi:10.1248/bpb.25.622. PMID 12033503.
- ↑ Liang T, Liao S (July 1992). "Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids". The Biochemical Journal. 285 ( Pt 2) (2): 557–62. doi:10.1042/bj2850557. PMC 1132824. PMID 1637346.
- ↑ Liu J, Shimizu K, Kondo R (April 2009). "Anti-androgenic activity of fatty acids". Chemistry & Biodiversity. 6 (4): 503–12. doi:10.1002/cbdv.200800125. PMID 19353546.
- ↑ Lo S, King I, Alléra A, Klingmüller D (April 2007). "Effects of various pesticides on human 5alpha-reductase activity in prostate and LNCaP cells". Toxicology in Vitro. 21 (3): 502–8. doi:10.1016/j.tiv.2006.10.016. PMID 17218080.
- 1 2 Kumar N, Rungseevijitprapa W, Narkkhong NA, Suttajit M, Chaiyasut C (February 2012). "5α-reductase inhibition and hair growth promotion of some Thai plants traditionally used for hair treatment". Journal of Ethnopharmacology. 139 (3): 765–71. doi:10.1016/j.jep.2011.12.010. PMID 22178180.